These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 17923495

  • 1. Activity of the novel macrolide BAL19403 against ribosomes from erythromycin-resistant Propionibacterium acnes.
    Dreier J, Amantea E, Kellenberger L, Page MG.
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4361-5. PubMed ID: 17923495
    [Abstract] [Full Text] [Related]

  • 2. Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
    Heller S, Kellenberger L, Shapiro S.
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1956-61. PubMed ID: 17387155
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
    Ross JI, Snelling AM, Eady EA, Cove JH, Cunliffe WJ, Leyden JJ, Collignon P, Dréno B, Reynaud A, Fluhr J, Oshima S.
    Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth.
    Goldman RC, Kadam SK.
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1058-66. PubMed ID: 2506804
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term administration of oral macrolides for acne treatment increases macrolide-resistant Propionibacterium acnes.
    Nakase K, Okamoto Y, Aoki S, Noguchi N.
    J Dermatol; 2018 Mar; 45(3):340-343. PubMed ID: 29235673
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
    Lim YH, Kim IH, Seo JJ.
    J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.
    Lucier TS, Heitzman K, Liu SK, Hu PC.
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2770-3. PubMed ID: 8593017
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
    Gloor M, Wasik B, Becker A, Höffler U.
    Dermatology; 2002 Dec; 205(3):260-4. PubMed ID: 12399674
    [Abstract] [Full Text] [Related]

  • 14. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.
    Eady EA, Cove JH, Holland KT, Cunliffe WJ.
    Br J Dermatol; 1989 Jul; 121(1):51-7. PubMed ID: 2527056
    [Abstract] [Full Text] [Related]

  • 15. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.
    Shortridge VD, Zhong P, Cao Z, Beyer JM, Almer LS, Ramer NC, Doktor SZ, Flamm RK.
    Antimicrob Agents Chemother; 2002 Mar; 46(3):783-6. PubMed ID: 11850262
    [Abstract] [Full Text] [Related]

  • 16. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V, Kosowska K, Bozdogan B, Kelly LM, Smith K, Ednie LM, Lin G, Credito KL, Clark CL, McGhee P, Pankuch GA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [Abstract] [Full Text] [Related]

  • 17. Resistance of propionibacteria to antibiotics used in the treatment of acne.
    Brown JM, Poston SM.
    J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis.
    Llano-Sotelo B, Dunkle J, Klepacki D, Zhang W, Fernandes P, Cate JH, Mankin AS.
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4961-70. PubMed ID: 20855725
    [Abstract] [Full Text] [Related]

  • 20. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.
    Hasenbein ME, Warner JE, Lambert KG, Cole SE, Onderdonk AB, McAdam AJ.
    J Clin Microbiol; 2004 Apr; 42(4):1559-63. PubMed ID: 15071004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.